Calamine
FDA Label NDC 59970-075

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Navarro Discount Pharmacies, Llc for the product Calamine (NDC 59970-075). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, uses, warnings, when using this product, stop use and ask a doctor if, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Calamine 8%

Pramoxine HCl 1%

Purpose

Skin protectant

Topical analgesic

Uses

temporarily relieves pain and itching associated with:

  • rashes due to poison ivy, poison oac or poison sumac
  • insect bites
  • minor skin irritation
  • minor cuts
  • dries the oozing and weeping of poison ivy, poison oak and poison sumac

Warnings

For external use only.

When Using This Product

do not get into eyes

Stop Use And Ask A Doctor If

  • condition worsens or does not improve within 7 days
  • symptoms persist for more than 7 days or clear up and occur again within a few days

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • shake well before use
  • adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily
  • children under 2 years of age: ask a doctor

Other Information

  • store at 20° to 25°C (68° to 77°F)

Inactive Ingredients

SD alcohol 38-B, camphor, diazolidinyl urea, fragrance, hypromellose, methylparaben, polysorbate 80, propylene glycol, propylparaben, purified water, zanthan gum

Package Label

Image Of Bottle Label (Calamine.nav.bottle)

Image Of Bottle Label (Calamine.nav.bottle)

* Please review the disclaimer below.